Plain-English translation of NCT05881447 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
RenalTWO is a research study that follows people over time to learn how common kidney disease is in rural Sub-Saharan Africa and who is most likely to develop it. Researchers will collect information about your health, medical history, lifestyle, and take blood and other measurements to understand the patterns and risks. This isn't testing a new medication — it's trying to understand kidney disease better in this region.
Kidney disease is a serious health problem worldwide, but we don't know much about how often it happens or who is most at risk in rural African communities. This study aims to fill that gap so doctors can better identify and help people at highest risk.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic three times over one year: once when you join, again after at least 90 days, and once more after a full year. At each visit, the research team will check your vital signs (blood pressure, weight, height), ask about your medical history and lifestyle, and collect a blood sample. You may also be asked to wear a step counter for one week to track your physical activity. The whole process takes about one year total.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Tanzania
Collaborators
University Hospital, Basel, Switzerland, Ifakara Health Institute
Enrollment target
~1,200 participants
Started
June 2023
Primary completion
December 2026
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nikolai C Hodel, MSc
Swiss Tropical & Public Health Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.